Biomedical Applications of Trastuzumab: As a Therapeutic Agent and a Targeting Ligand-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biomedical Applications of Trastuzumab: As a Therapeutic Agent and a Targeting Ligand

Published:2015-04-01 Issue:4 Volume:35 Page:849-876
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med. Res. Rev.

Author:

Kulhari Hitesh¹²³,Pooja Deep²,Rompicharla Sri V. K.²,Sistla Ramakrishna²,Adams David J.³

Affiliation:

1. IICT-RMIT Research Centre, CSIR-Indian Institute of Chemical Technology; Hyderabad 500007 India

2. Medicinal Chemistry & Pharmacology Division; CSIR-Indian Institute of Chemical Technology; Hyderabad 500007 India

3. Health Innovations Research Institute; RMIT University; Melbourne VIC 3083 Australia

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/med.21345/fullpdf

Reference104 articles.

1. Antibody targeted drugs as cancer therapeutics;Schrama;Nat Rev Drug Disc,2006

2. Trastuzumab in gastric cancer;Okines;Eur J Cancer,2010

3. The discovery of receptor tyrosine kinases: Targets for cancer therapy;Gschwind;Nat Rev Cancer,2004

4. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001

5. The role of HER2 in cancer therapy and targeted drug delivery;Tai;J Control Release,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes;Cancer Treatment Reviews;2024-11

2. Stability of trastuzumab during nanomedicine formulation using SEC-HPLC coupled with polyacrylamide gel electrophoresis;Pharmaceutical Development and Technology;2023-03-23

3. Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma;International Journal of Biological Sciences;2023

4. The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?;Technology in Cancer Research & Treatment;2023-01

5. Review on Metal-Based Theranostic Nanoparticles for Cancer Therapy and Imaging;Technology in Cancer Research & Treatment;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3